Statement Of Cash Flows [Abstract]
| Concept |
2024-01-01 to 2024-12-31 |
2023-01-01 to 2023-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Adjustments for decrease (increase) in trade and other receivables |
77,152,000
DKK
|
113,955,000
DKK
|
| Adjustments for depreciation and amortisation expense and impairment loss (reversal of impairment loss) recognised in profit or loss |
704,306,000
DKK
|
637,209,000
DKK
|
| Adjustments for gains (losses) on change in fair value less costs to sell, biological assets |
368,909,000
DKK
|
141,665,000
DKK
|
| Adjustments for undistributed profits of investments accounted for using equity method |
46,964,000
DKK
|
70,652,000
DKK
|
| Cash flows from (used in) financing activities [abstract] | ||
| Cash flows from (used in) increase (decrease) in current borrowings |
464,919,000
DKK
|
546,241,000
DKK
|